Biocon is a global biopharmaceutical company based in India, founded in 1978 by Kiran Mazumdar-Shaw. It specializes in the development of innovative therapies for various diseases, including diabetes, cancer, and autoimmune disorders. The company focuses on biotechnology and has a strong emphasis on research and development. Biocon operates in multiple segments, including generic pharmaceuticals, biosimilars, and novel biologics. It has established partnerships with several international organizations to expand its reach and enhance its product offerings. With a commitment to affordable healthcare, Biocon aims to make advanced therapies accessible to patients worldwide.